[Other] Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor–Positive Metastatic Breast Cancer: MAINTAIN Trial

Emmanuelgim Post time The day before yesterday 07:02 | Show all posts |Read mode
Reward30points

Title: Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: MAINTAIN Trial

journal:Journal of Clinical Oncology

Authors:Kevin Kalinsky; Melissa K. Accordino; Codruta Chiuzan; Prabhjot S. Mundi; Elizabeth Sakach; Claire Sathe; Heejoon Ahn; Meghna S. Trivedi; Yelena Novik; Amy Tiersten; George Raptis; Lea N. Baer; Sun Y. Oh; Amelia B. Zelnak; Kari B. Wisinski; Eleni Andreopoulou; William J. Gradishar; Erica Stringer-Reasor; Sonya A. Reid; Anne O'Dea; Ruth O'Regan; Katherine D. Crew; Dawn L. Hershman

Published date:2023-8-20

DOI:10.1200/jco.22.02392

PDF link:https://ascopubs.org/doi/pdfdirect/10.1200/JCO.22.02392

Article link:http://dx.doi.org/10.1200/jco.22.02392

Article Source:American Society of Clinical Oncology (ASCO)


Remark:

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
flyer93 Post time The day before yesterday 07:02 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    70

Latest Reply

Return to the list